• ÆäÀ̽ººÏ °øÀ¯
  • Æ®À§ÅÍ °øÀ¯
  • ¹ÌÅõµ¥ÀÌ °øÀ¯
  • URLº¹»ç
  • ´õº¸±â
  • °ü½ÉÀÇ·áÁø µî·Ï

ÀÓµµ¼±

  • Áø·á°ú

    ¼øÈ¯±â³»°ú

  • Àü¹®Áø·áºÐ¾ß

    Çù½ÉÁõ, ½É±Ù°æ»ö, Àӻ󿬱¸, ½ÉÇ÷°üÁßÀç½Ã¼ú (È­: ÃÊÁø¸¸)

  • ´ã´çŬ¸®´Ð

    ÈäÅëŬ¸®´Ð

  • °ü·Ã¼¾ÅÍ

    ½ÉÇ÷°ü¼¾ÅÍ

ÀÓµµ¼±

ÀÓµµ¼± ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
¼øÈ¯±â³»°ú - - - - - - Çù½ÉÁõ , ½É±Ù°æ»ö , Àӻ󿬱¸ , ½ÉÇ÷°üÁßÀç½Ã¼ú (È­: ÃÊÁø¸¸)
½ÉÇ÷°ü¼¾ÅÍ
¿ÀÀü
¿ÀÀü
- - - - Çù½ÉÁõ , ½É±Ù°æ»ö , Àӻ󿬱¸ , ½ÉÇ÷°üÁßÀç½Ã¼ú

ÀÓµµ¼± ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1996 .03  ~  1998 .02  :  °í·Á´ëÇб³ ´ëÇпø ¹Ú»ç, ¼øÈ¯±â³»°úÇÐ
  • 1993 .03  ~  1995 .02  :  °í·Á´ëÇб³ ´ëÇпø ¼®»ç, ³»°úÇÐ
  • 1980 .03  ~  1986 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ Á¹¾÷

°æ·Â

more
  • 2017 .03  ~  2017 .12  :  °í·Á´ëÇб³ À¶ÇÕ¿¬±¸¿øÀå
  • 2016 .09  ~  2017 .12  :  °í·Á´ëÇб³ ¿¬±¸Ã³Àå
  • 2015 .09  ~   :  °í´ë¾È¾Ïº´¿ø¿¬±¸Àü´ãÀÇ»ç ÁöÁ¤
  • 2006 .03  ~   :  °í·Á´ëÇб³ Àǰú´ëÇÐ ¼øÈ¯±â³»°ú ±³¼ö
  • 2014 .02  ~  2016 .01  :  °í´ë¾È¾Ïº´¿ø °Ç°­°ËÁø¼¾ÅͼÒÀå
  • 2014 .02  ~  2014 .08  :  °í´ë¾È¾Ïº´¿ø ½ÉÇ÷°ü¼¾ÅÍÀå
  • 2012 .02  ~  2014  :  °í´ë¾È¾Ïº´¿ø ¼øÈ¯±â³»°ú °úÀå
  • 2004 .09  ~  2007 .08  :  °í´ë¾È¾Ïº´¿ø ½ÉµµÀÚ½ÇÀå
  • 2000 .09  ~  2006 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ¼øÈ¯±â³»°ú ºÎ±³¼ö
  • 2000 .08  ~  2001 .02  :  Research Fellow, University of Texas, Houston, USA
  • 1999 .02  ~  2000 .08  :  Research Fellow, Baylor College of Medicine, Houston, USA
  • 1998 .03  ~  2000 .08  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ¼øÈ¯±â³»°ú Á¶±³¼ö
  • 1994 .03  ~  1998 .02  :  °í´ë¾È¾Ïº´¿ø ¼øÈ¯±â³»°ú ÀüÀÓÀÇ
  • 1990 .03  ~  1994 .02  :  °í´ë¾È¾Ïº´¿ø ³»°ú Àü°øÀÇ
  • 1989 .03  ~  1990 .02  :  °í·Á´ëÇб³ ºÎ¼Óº´¿ø ¼ö·ÃÀÇ

¼ö»ó³»¿ª

more
  • 2018 .02  :  °í·Á´ëÇб³ °íÀÇÀÇÇлó
  • 2017 .11  :  °í·Á´ëÇб³ ¼®Å¾°­ÀÇ»ó
  • 2017 .05  :  °í·Á´ëÇб³ ¼®Å¾¿¬±¸»ó ¼ö»ó
  • 2011 .04  :  º¸°Çº¹ÁöºÎ Àå°üǥâ
  • 2010  :  °í´ë¾È¾Ïº´¿øÀ» ºû³½ Àι° ¼±Á¤
  • 2010 .08  :  ¹Ì±¹±¹Á¦ÀθíÁ¤º¸±â°ü(ABI,American Biographical Institute) ¡ºUniversal Award of Accomplishment ¡» µîÀç
  • 2009  :  °¡»ó½Å¾à°³¹ß ¿¬±¸Áø ¼±Á¤. ¾Æ½ºÆ®¶óÁ¦³×Ä«, Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø
  • 2009 .12  :  ¹Ì±¹ ¸¶¸£ÄûÁî ÈÄÁîÈÄ(Marquis Who's Who) ¡ºMarquis Who's Who in the World 2010¡» µîÀç
  • 2008  :  ´ëÇѼøÈ¯±âÇÐȸ Á¦52Â÷ Ãß°èÇмú´ëȸ ¿ì¼ö½É»çÀ§¿ø»ó ¼ö»ó
  • 1995  :  ´ëÇѼøÈ¯±âÇÐȸ Á¦ 1ȸ ÀþÀº¿¬±¸ÀÚ»ó ¼ö»ó

ÇÐȸȰµ¿

more
  • 2018 .01  ~  2019 .12  :  ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ±¸Á¶½ÉÁúȯ¿¬±¸È¸ ȸÀå
  • 2017 .05  ~  2019 .08  :  ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ »êÇÏ Ç÷¼ÒÆÇ-Ç÷Àü¿¬±¸È¸ ȸÀå
  • 2016 .04  ~   :  ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ºñ»óÀÓÀÌ»ç
  • 2015 .01  ~   :  Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈ­ÇÐȸ ÆòÀÇ¿ø
  • 2014 .04  ~  2016 .03  :  ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ÇмúÀÌ»ç
  • 2014 .01  ~   :  ´ëÇѽÉÀåÇÐȸ ±âÃʰúÇבּ¸È¸ ¿î¿µÀ§¿ø
  • 2010 .01  ~   :  ´ëÇѽÉÀåÇÐȸÁö(KJC) ³í¹®½É»çÀ§¿ø
  • 2013 .01  ~  2014 .12  :  ¼¼°è³»°úÇÐȸ Á¶Á÷À§¿øÈ¸ °£ÇàÀ§¿øÀå
  • 2012 .04  ~  2014 .03  :  ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ¿¬±¸ÀÌ»ç
  • 2010 .04  ~  2012 .03  :  ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ÀÎÁõÁ¦°ü¸®ÀÌ»ç
  • 2009 .03  ~  2013 .02  :  ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ »êÇÏ ½ºÅÙÆ®³» ÀçÇùÂø¿¬±¸È¸ ȸÀå
  • 2009 .01  ~  2010 .12  :  Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈ­ÇÐȸ ±¹Á¦À§¿øÈ¸ À§¿øÀå
  • 2007 .06  ~  2009 .02  :  ´ëÇѰíÇ÷¾ÐÇÐȸ ¿¬±¸À§¿ø
  • 2007 .01  ~  2008 .12  :  Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈ­ÇÐȸ º¸Çè¹ýÁ¦À§¿øÈ¸ À§¿øÀå
  • 2006 .10  ~  2008 .09  :  ´ëÇѼøÈ¯±âÇÐȸ ¿¬±¸À§¿ø
  • 2004 .10  ~  2006 .09  :  ´ëÇѼøÈ¯±âÇÐȸ ÇмúÀ§¿ø
  • 2002 .10  ~  2004 .09  :  ´ëÇѼøÈ¯±âÇÐȸ °£ÇàÀ§¿ø
  • 2002 .10  ~  2004 .10  :  ´ëÇѽÉÀåÇÐȸÁö ÆíÁýÀ§¿ø
  •  ~   :  ´ëÇÑÁßȯÀÚÀÇÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇѼøÈ¯±âÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇѳ»°úÇÐȸ Á¤È¸¿ø

±¹³»È°µ¿

more
  • 2019 .01  ~   :  ´ëÇѹα¹ÀÇÇÐÇѸ²¿ø Á¤È¸¿ø
  • 2018 .07  ~   :  ¢ßÀÎÅØ¹ÙÀÌ¿À ÀÓ»óÇù·Â
  • 2014 .02  ~   :  ¼­¿ï½Ã ´ë»çÁõÈıº°ü¸®»ç¾÷ Áö¿ø´ÜÀå
  • 2013 .05  ~  2019 .05  :  ¼­¿ïƯº°½Ã ¼­¿ïÀÇ·á¿ø ºñ»óÀÓÀÌ»ç
  • 2013 .04  ~   :  °í·Á´ëÇб³ ºÎ¼³ ´ë»çÁõÈıº¿¬±¸¼ÒÀå
  • 2011 .08  ~   :  »ç´Ü¹ýÀÎ ½ÉÇ÷°ü°Ç°­ÁõÁø¿¬±¸¿ø ´ëÇ¥ÀÌ»ç
  • 2008 .01  ~  2017 .03  :  ´ëÇÑ»çȸº¹Áöȸ ÀÌ»ç
  • 2012 .06  ~  2014 .05  :  °í·Á´ëÇб³ ÃâÆÇºÎ ÃâÆÇ±âȹÀ§¿ø
  • 2011 .12  ~  2013 .12  :  Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø À§¾àǰºÐ¾ß ǰÁúÀÎÁõ½ÉÀÇÀ§¿ø
  • 2009 .03  ~  2011 .02  :  º¸°Çº¹ÁöºÎ º¸°ÇÀÇ·á±â¼úÁ¤Ã¥½ÉÀÇÀ§¿øÈ¸ ºÐ¾ßº° Àü¹®À§¿ø

³í¹®

more
  • [SCI] (Subclassification of CYP2C19 Genotyping for Better-Adjusted Thienopyridine Treatment)
  • [SCI] (Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial)
  • [SCI] (A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data)
  • [SCI] (Thymosin beta 4-Enhancing Therapeutic Efficacy of Human Adipose-Derived Stem Cells in Mouse Ischemic Hindlimb Model)
  • [SCI] (Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients)
  • [SCI] (Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention with Current-Generation Drug-Eluting Stent)
  • [SCI] (A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions)
  • [SCI] (Modulating cardiomyocyte and fibroblast interaction using layer-by-layer deposition facilitates synchronisation of cardiac macro tissues)
  • [SCI] (Cardioprotective effects of genetically engineered cardiac stem cells by spheroid formation on ischemic cardiomyocytes)
  • [SCI] (Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up)
  • [SCI] (In-hospital outcome differences between transradial and transfemoral coronary approaches: Data from the Korean percutaneous coronary intervention registry)
  • [SCI] (A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data)
  • [SCI] (Favorable neurological outcome after ischemic cerebrovascular events in patients treated with percutaneous left atrial appendage occlusion compared with warfarin)
  • [SCI] (The clinical impact of sex differences on ischemic postconditioning during primary percutaneous coronary intervention: a POST (the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction) substudy)
  • [SCI] (Efficacy of postprocedural anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A post-hoc analysis of the randomized INNOVATION trial)
  • [SCI] (Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation)
  • [SCI] (Manipulation of the response of human endothelial colony-forming cells by focal adhesion assembly using gradient nanopattern plates)
  • [SCI] (Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study)
  • [SCI] (Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting A Prospective, Randomized, Crossover Trial)
  • [SCI] (Nanopillar Surface Topology Promotes Cardiomyocyte Differentiation through Cofilin-Mediated Cytoskeleton Rearrangement2)
  • [SCI] (Transplantation of Adipose-Derived Stem Cell Sheet Attenuates Adverse Cardiac Remodeling in Acute Myocardial Infarction)
  • [SCI] (INNOVATION Study (Impact of Immediate Stent Implantation Versus Deferred Stent Implantation on Infarct Size and Microvascular Perfusion in Patients With ST-Segment-Elevation Myocardial Infarction))
  • [SCI] (Prospective randomized comparison of clinical and angiographic outcomes between everolimus-eluting versus zotarolimus-eluting stents for treatment of coronary restenosis in drug-eluting stents: intravascular ultrasound volumetric analysis: (RESTENT-ISR Trial))
  • [SCI] (The Changes of Individual Carotid Artery Wall Layer by Aging and Carotid Intima-Media Thickness Value for High Risk.)
  • [SCI] (A comparison of clinical outcomes between triple antithrombotic therapy versus dual antiplatelet with left atrial appendage occlusion in patients with atrial fibrillation undergoing drug-eluting stent implantation)
  • [SCI] (Comparison of Ticagrelor versus Prasugrel on Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients with Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting: Prospective, Randomized, Cross-Over Design)
  • [SCI] (Optical coherence tomography (OCT) guided percutaneous coronary intervention : clinical impact of acute abnormal findings after drug-eluting stent implantation detected only by OCT)
  • [SCI] (Transplantation of Adipose-Derived Stem Cell Sheet Attenuates Adverse Cardiac Remodeling in Acute Myocardial Infarction)
  • [SCI] (Prospective randomized comparison of clinical and angiographic outcomes between everolimus-eluting versus zotarolimus-eluting stents for treatment of coronary restenosis in drug-eluting stents: intravascular ultrasound volumetric analysis: (RESTENT-ISR Trial))
  • [SCI] (The Changes of Individual Carotid Artery Wall Layer by Aging and Carotid Intima-Media Thickness Value for High Risk)
  • [SCI] (The Seoul Metropolitan Lifestyle Intervention Program and Metabolic Syndrome Risk: A Retrospective Database Study)
  • [SCI] (Intrinsic FGF2 and FGF5 promotes angiogenesis of human aortic endothelial cells in 3D microfluidic angiogenesis system)
  • [SCI] (Comparison of 2-year clinical outcomes between diabetic versus nondiabetic patients with acute myocardial infarction after 1-month stabilization: Analysis of the prospective registry of DIAMOND (DIabetic acute myocardial infarctiON Disease) in Korea: an observational registry study)
  • [SCI] (Intramyocardial Adipose-Derived Stem Cell Transplantation Increases Pericardial Fat with Recovery of Myocardial Function after Acute Myocardial Infarction)
  • [SCI] (Brachial-ankle pulse wave velocity is associated with composite carotid and coronary atherosclerosis in a middle-aged asymptomatic population)
  • [SCI] (Cardiac stem cell secretome protects cardiomyocytes from hypoxic injury partly via MCP-1-dedendent mechanism)
  • [SCI] (Left Atrial Appendage Occlusion in Non-Valvular Atrial Fibrillation in a Korean Multi-Center Registry)
  • [SCI] (Black Raspberry Extract Increased Circulating Endothelial Progenitor Cells and Improved Arterial Stiffness in Patients with Metabolic Syndrome: A Randomized Controlled Trial)
  • [SCI] (Different impacts of acute myocardial infarction on left ventricular apical and basal rotation.)
  • [SCI] (Efficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS]).)
  • (Relationship between ultrasonic tissue characterization and myocardial deformation for prediction of left ventricular reverse remodelling in non-ischaemic dilated cardiomyopathy)
  • [SCI] (Six-Month versus Twelve-Month Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents: 'EXCELLENT' Randomized, Multicenter Study.)
  • [SCI] (The relationship between mechanical properties of carotid artery and coronary artery disease)
  • [SCI] (A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease)
  • [SCI] (Everolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention The EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) Randomized Trial)
  • [SCI] (Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up)
  • [SCI] (Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients)
  • [SCI] (Angiopoietin-1 promotes endothelial differentiation from embryonic stem cells and induced pluripotent stem cells)
  • [SCI] (Intramyocardial transplantation of human adipose-derived stromal cell and endothelial progenitor cell mixture was not superior to individual cell type transplantation in improving left ventricular function in rats with myocardial infarction)
  • [SCI] (Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease)
  • [SCI] (Stent Thrombosis and Bleeding Complications After Implantation of Sirolimus-Eluting Coronary Stents in an Unselected Worldwide Population A Report From the e-SELECT (Multi-Center Post-Market Surveillance) Registry)
  • [SCI] (Red Ginseng Extract Improves Coronary Flow Reserve and Increases Absolute Numbers of Various Circulating Angiogenic Cells in Patients with First ST-Segment Elevation Acute Myocardial Infarction)
  • [SCI] (Cellular and Molecular Changes Associated With Inhibitory Effect of Pioglitazone on Neointimal Growth in Patients With Type 2 Diabetes After Zotarolimus-Eluting Stent Implantation)

Àú¼­

more
  • ±¸Á¶½ÉÁúȯ ¸Å´º¾ó
  • ½ÉÀåÀçȰÀ» À§ÇÑ ¿îµ¿°ú »ýȰ¿ä¹ý
  • 3î¸(Àú) ¹ä»ó
  • The Manual of Interventional Cardiology(ÁßÀç½Ã¼ú¸Å´º¾ó)
  • ½ÉÀå¿¡°Ô ¸» °É±â
  • Textbook of Geriatric Medicine International
  • °¡½¿ÀÌ ¾ÆÆÄ¿ä

ÃÖÁ¾¼öÁ¤ÀÏ : 2020.11.16